Literature DB >> 29670211

Epidemiology and biology of relapse after stem cell transplantation.

Mary Horowitz1, Hans Schreiber2, Alex Elder3, Olaf Heidenreich3, Josef Vormoor3,4, Christina Toffalori5, Luca Vago5,6, Nicolaus Kröger7.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29670211      PMCID： PMC6282701          DOI： 10.1038/s41409-018-0171-z

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN： 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  104 in total

Review 1.  Immunotherapy with CTLs restricted by nonself MHC.

Authors:  H J Stauss
Journal:  Immunol Today       Date:  1999-04

Review 2.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

3.  IFN-gamma- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers.

Authors:  Bin Zhang; Theodore Karrison; Donald A Rowley; Hans Schreiber
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

4.  Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.

Authors:  Philip L McCarthy; Theresa Hahn; Anna Hassebroek; Christopher Bredeson; James Gajewski; Gregory Hale; Luis Isola; Hillard M Lazarus; Stephanie J Lee; Charles F Lemaistre; Fausto Loberiza; Richard T Maziarz; J Douglas Rizzo; Steven Joffe; Susan Parsons; Navneet S Majhail
Journal:  Biol Blood Marrow Transplant       Date:  2013-05-06       Impact factor: 5.742

5.  NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications.

Authors:  Antonio Russo; Giacomo Oliveira; Sofia Berglund; Raffaella Greco; Valentina Gambacorta; Nicoletta Cieri; Cristina Toffalori; Laura Zito; Francesca Lorentino; Simona Piemontese; Mara Morelli; Fabio Giglio; Andrea Assanelli; Maria Teresa Lupo Stanghellini; Chiara Bonini; Jacopo Peccatori; Fabio Ciceri; Leo Luznik; Luca Vago
Journal:  Blood       Date:  2017-10-06       Impact factor: 22.113

6.  Eradication of Large Solid Tumors by Gene Therapy with a T-Cell Receptor Targeting a Single Cancer-Specific Point Mutation.

Authors:  Matthias Leisegang; Boris Engels; Karin Schreiber; Poh Yin Yew; Kazuma Kiyotani; Christian Idel; Ainhoa Arina; Jaikumar Duraiswamy; Ralph R Weichselbaum; Wolfgang Uckert; Yusuke Nakamura; Hans Schreiber
Journal:  Clin Cancer Res       Date:  2015-12-14       Impact factor: 12.531

7.  Bystander elimination of antigen loss variants in established tumors.

Authors:  Michael T Spiotto; Donald A Rowley; Hans Schreiber
Journal:  Nat Med       Date:  2004-02-22       Impact factor: 53.440

8.  Loss of mismatched HLA detected in the peripheral blood of an AML patient who relapsed after haploidentical hematopoietic stem cell transplantation.

Authors:  Borae G Park; Yong Hak Sohn; Heung Bum Oh; Eul Ju Seo; Seongsoo Jang; Sun Pyo Hong
Journal:  Ann Lab Med       Date:  2015-09       Impact factor: 3.464

Review 9.  Fibroblast heterogeneity in the cancer wound.

Authors:  Daniel Öhlund; Ela Elyada; David Tuveson
Journal:  J Exp Med       Date:  2014-07-28       Impact factor: 14.307

10.  Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.

Authors:  J R Passweg; H Baldomero; P Bader; C Bonini; R F Duarte; C Dufour; A Gennery; N Kröger; J Kuball; F Lanza; S Montoto; A Nagler; J A Snowden; J Styczynski; M Mohty
Journal:  Bone Marrow Transplant       Date:  2017-03-13       Impact factor: 5.483
View more
  26 in total

1.  Quantitative chimerism in CD3-negative mononuclear cells predicts prognosis in acute myeloid leukemia patients after hematopoietic stem cell transplantation.

Authors:  Anne Bouvier; Jérémie Riou; Sylvain Thépot; Aurélien Sutra Del Galy; Sylvie François; Aline Schmidt; Corentin Orvain; Marie-Hélène Estienne; Alban Villate; Damien Luque Paz; Laurane Cottin; Bénédicte Ribourtout; Annaëlle Beucher; Yves Delneste; Norbert Ifrah; Valérie Ugo; Mathilde Hunault-Berger; Odile Blanchet
Journal:  Leukemia       Date:  2019-11-25       Impact factor: 11.528

2.  Alpha-1 Antitrypsin-Expressing Mesenchymal Stromal Cells Confer a Long-Term Survival Benefit in a Mouse Model of Lethal GvHD.

Authors:  Sabine Geiger; Emrah I Ozay; Ulf Geumann; Marina K Hereth; Terese Magnusson; Sudarvili Shanthalingam; Daniela Hirsch; Stefanie Kälin; Christine Günther; Barbara A Osborne; Gregory N Tew; Felix G Hermann; Lisa M Minter
Journal:  Mol Ther       Date:  2019-05-16       Impact factor: 11.454

3.  Learning the next-generation sequencing alphabet of immune reconstitution: factors determining CD8+ T-cell receptor α-chain repertoire dynamics after hematopoietic stem cell transplantation.

Authors:  Esteban Arrieta-Bolaños; Katharina Fleischhauer
Journal:  Haematologica       Date:  2019-03       Impact factor: 9.941

4.  Clonal evolution and immune evasion in posttransplantation relapses.

Authors:  Luca Vago
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

Review 5.  T cell optimization for graft-versus-leukemia responses.

Authors:  Melinda A Biernacki; Vipul S Sheth; Marie Bleakley
Journal:  JCI Insight       Date:  2020-05-07

Review 6.  Summary of the Highlights of 2019 ASTCT Meeting by iNDUS BMT Group at Chennai, India.

Authors:  Ajay Sharma; Biju George; Chezian Subhash; Dinesh Bhurani; Dharma Choudhary; Jose Easow; Joseph John; Lalit Kumar; Neeraj Sidharthan; Pankaj Malhotra; Rayaz Ahmed; Revathy Raj; Rahul Bhargava; Satya Prakash Yadav; Sharat Damodar; Soniya Nityanand; Sunil Bhat; Tapan Saikia; Tulika Seth; Velu Nair; Vikram Mathews
Journal:  Indian J Hematol Blood Transfus       Date:  2019-06-21       Impact factor: 0.900

Review 7.  Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Lacey Williams; Kimberley Doucette; Judith E Karp; Catherine Lai
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

8.  Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation.

Authors:  Kevin-James Wattebled; Elodie Drumez; Valérie Coiteux; Léonardo Magro; Micha Srour; Paul Chauvet; Bruno Quesnel; Alain Duhamel; Ibrahim Yakoub-Agha; David Beauvais
Journal:  Ann Hematol       Date:  2022-03-29       Impact factor: 3.673

9.  Posttransplant blockade of CXCR4 improves leukemia complete remission rates and donor stem cell engraftment without aggravating GVHD.

Authors:  Long Su; Ming-Hui Fang; Jun Zou; Su-Jun Gao; Xiao-Yi Gu; Xian-Di Meng; Xue Wang; Zheng Hu; Yong-Guang Yang
Journal:  Cell Mol Immunol       Date:  2021-10-11       Impact factor: 11.530

10.  Galectin-9 and PSMB8 overexpression predict unfavorable prognosis in patients with AML.

Authors:  Yongping Zhang; Song Xue; Qi Hao; Fuhong Liu; Wenqiu Huang; Jingbo Wang
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.